| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |